Patentable/Patents/US-7820809
US-7820809

Functional and hyperfunctional siRNA directed against Bcl-2

PublishedOctober 26, 2010
Assigneenot available in USPTO data we have
Inventorsnot available in USPTO data we have
Technical Abstract

Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rationale design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes.

Patent Claims
9 claims

Legal claims defining the scope of protection, as filed with the USPTO.

1

1. An siRNA molecule effective at silencing Bcl-2 expression, wherein said siRNA molecule consists of: (a) a duplex region; and (b) either no overhang regions or at least one overhang region, wherein each overhang region comprises six or fewer nucleotides, wherein said duplex region consists of a sense region and an antisense region, wherein said sense region and said antisense region together form said duplex region and said duplex region is 19 base pairs in length and said antisense region comprises a sequence that is the complement of SEQ ID NO: 301.

2

2. The siRNA molecule of claim 1 , wherein said siRNA molecule has at least one overhang region.

3

3. The siRNA molecule of claim 1 , wherein said siRNA molecule has no overhang regions.

4

4. A chemically synthesized double-stranded siRNA molecule, wherein: (a) each strand of said double-stranded siRNA molecule is 19 nucleotides in length; and (b) one strand of said double-stranded siRNA molecule comprises a sequence that is the complement of SEQ ID NO: 301.

5

5. An siRNA molecule consisting of: (a) a duplex region; and (b) either no overhang regions or at least one overhang region, wherein each overhang region comprises six or fewer nucleotides, wherein the duplex region is nineteen base pairs in length and consists of a sense region that has a sequence that is the same as SEQ ID NO: 301 and an antisense sequence that is the complement of SEQ ID NO: 301.

6

6. The siRNA molecule of claim 5 , wherein said siRNA molecule has no overhang regions.

7

7. The siRNA molecule of claim 5 , wherein said siRNA molecule has at least one overhang region.

8

8. The siRNA molecule of claim 7 , wherein said siRNA molecule has one overhang region.

9

9. The siRNA molecule of claim 7 , wherein said siRNA molecule has two overhang regions.

Classification Codes (CPC)

Cooperative Patent Classification codes for this invention. Click any code to explore related patents in that topic.

Patent Metadata

Filing Date

March 18, 2005

Publication Date

October 26, 2010

Want to explore more patents?

Browse 5M+ US patents with plain-English claim translations and AI-generated analysis.

Citation & reuse

Analysis on this page is generated by Patentable — an AI-powered patent intelligence platform. AI-generated summaries, explanations, and analysis may be reused with attribution and a visible link back to the canonical URL below. Patent abstracts and claims are USPTO public domain.

Cite as: Patentable. “Functional and hyperfunctional siRNA directed against Bcl-2” (US-7820809). https://patentable.app/patents/US-7820809

© 2026 Patentable. All rights reserved.

Patentable is a research and drafting-assistant tool, not a law firm, and does not provide legal advice. Documents we generate are drafts for review by a licensed patent attorney.